Traws Pharma (TRAW) Exchange Rate Effect (2013 - 2026)
Traws Pharma (TRAW) posted quarterly Exchange Rate Effect of -$8000.0 for Q1 2026, down 134.78% year-over-year from $23000.0 in Q1 2025, and down 166.67% quarter-over-quarter from -$3000.0 in Q3 2025.
Traws Pharma (TRAW) Exchange Rate Effect (2013 - 2026) Analysis & Trends
Traws Pharma (TRAW) has reported Exchange Rate Effect for 14 consecutive years, with -$8000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Exchange Rate Effect fell 134.78% year-over-year to -$8000.0; the TTM figure through Mar 2026 stood at $17000.0 (up 54.55% YoY), while the FY2025 annual figure was $48000.0, up 352.63% from the prior year.
- Exchange Rate Effect eased to -$8000.0 in Q1 2026 per TRAW's latest filing, from -$3000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $28000.0 in Q4 2022 and bottomed at -$20000.0 in Q2 2022.
- Historically, Exchange Rate Effect has averaged $800.0 across 5 years, with a median of -$3000.0 in 2024.
- Annual changes were most pronounced in 2022 — Exchange Rate Effect slumped 600.0% — and 2025, when it jumped 1033.33%.
- Traws Pharma's Exchange Rate Effect stood at $28000.0 in 2022, then slumped by 75.0% to $7000.0 in 2023, then slumped by 228.57% to -$9000.0 in 2024, then soared by 66.67% to -$3000.0 in 2025, then plunged by 166.67% to -$8000.0 in 2026.
- Business Quant data shows TRAW's Exchange Rate Effect at -$8000.0 in Q1 2026, -$3000.0 in Q3 2025, and $28000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -2.45 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -287,000.00 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.63 Mn |
| 10 | Traws Pharma | 5.60 Mn | 588,417.40 | - | -3,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8,000.00 |
| Mar 31, 2026 | -8,000.00 |
| Sep 30, 2025 | -3,000.00 |
| Sep 30, 2025 | -3,000.00 |
| Jun 30, 2025 | 28,000.00 |
| Jun 30, 2025 | 28,000.00 |
| Mar 31, 2025 | 23,000.00 |
| Mar 31, 2025 | 23,000.00 |
| Dec 31, 2024 | -9,000.00 |
| Dec 31, 2024 | -9,000.00 |
| Jun 30, 2024 | -3,000.00 |
| Jun 30, 2024 | -3,000.00 |
| Mar 31, 2024 | -7,000.00 |
| Mar 31, 2024 | -7,000.00 |
| Dec 31, 2023 | 7,000.00 |
| Dec 31, 2023 | 7,000.00 |
| Sep 30, 2023 | -2,000.00 |
| Sep 30, 2023 | -2,000.00 |
| Jun 30, 2023 | -1,000.00 |
| Jun 30, 2023 | -1,000.00 |